These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6356224)

  • 1. Inhibition of protease activity can lead to neurite extension in neuroblastoma cells.
    Monard D; Niday E; Limat A; Solomon F
    Prog Brain Res; 1983; 58():359-64. PubMed ID: 6356224
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurite outgrowth activity of protease nexin-1 on neuroblastoma cells requires thrombin inhibition.
    Gurwitz D; Cunningham DD
    J Cell Physiol; 1990 Jan; 142(1):155-62. PubMed ID: 2298818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolytic regulation of neurite outgrowth from neuroblastoma cells by thrombin and protease nexin-1.
    Cunningham DD; Gurwitz D
    J Cell Biochem; 1989 Jan; 39(1):55-64. PubMed ID: 2654147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential effects of astroglial-derived factors on neurite outgrowth: initiation by protease inhibitors and potentiation by extracellular matrix components.
    Shea TB; Beermann ML; Nixon RA
    J Neurosci Res; 1992 Feb; 31(2):309-17. PubMed ID: 1573681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of neurite outgrowth through protein kinase C and protease nexin-1 in neuroblastoma cell.
    Tsuneishi S
    Kobe J Med Sci; 1992 Jun; 38(3):147-59. PubMed ID: 1453685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin modulates and reverses neuroblastoma neurite outgrowth.
    Gurwitz D; Cunningham DD
    Proc Natl Acad Sci U S A; 1988 May; 85(10):3440-4. PubMed ID: 2835773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple proteases regulate neurite outgrowth in NB2a/dl neuroblastoma cells.
    Shea TB; Beermann ML; Nixon RA
    J Neurochem; 1991 Mar; 56(3):842-51. PubMed ID: 1993897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of phorbol ester tumor promoters and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells.
    Spinelli W; Sonnenfeld KH; Ishii DN
    Cancer Res; 1982 Dec; 42(12):5067-73. PubMed ID: 7139611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of neuroblastoma cells induced by an inhibitor of mevalonate synthesis: relation of neurite outgrowth and acetylcholinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis.
    Maltese WA; Sheridan KM
    J Cell Physiol; 1985 Dec; 125(3):540-58. PubMed ID: 3851809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of proteases and their inhibitors on neurite outgrowth from neonatal mouse sensory ganglia in culture.
    Hawkins RL; Seeds NW
    Brain Res; 1986 Nov; 398(1):63-70. PubMed ID: 3542123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of neurite outgrowth in the IMR-32 human neuroblastoma cell line by nerve growth factor.
    Reynolds CP; Perez-Polo JR
    J Neurosci Res; 1981; 6(3):319-25. PubMed ID: 6271984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor promoter receptors regulating neurite formation in cultured human neuroblastoma cells.
    Spinelli W; Ishii DN
    Cancer Res; 1983 Sep; 43(9):4119-25. PubMed ID: 6307504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an insulin-like growth factor binding protein-5 protease produced by rat articular chondrocytes and a neuroblastoma cell line.
    Matsumoto T; Gargosky SE; Kelley K; Rosenfeld RG
    Growth Regul; 1996 Sep; 6(3):185-90. PubMed ID: 8894652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient neuritogenesis in NB2a/d1 neuroblastoma cells induced by glial-derived protease inhibitors.
    Shea TB
    Cell Biol Int Rep; 1991 May; 15(5):437-43. PubMed ID: 1913850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and isolation of a trypsin-like serine protease from a long-term culture cytolytic T cell line and its expression by functionally distinct T cells.
    Kramer MD; Binninger L; Schirrmacher V; Moll H; Prester M; Nerz G; Simon MM
    J Immunol; 1986 Jun; 136(12):4644-51. PubMed ID: 2423597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A plasma nucleosome releasing factor (NRF) with serine protease activity is instrumental in removal of nucleosomes from secondary necrotic cells.
    Zeerleder S; Zwart B; te Velthuis H; Manoe R; Bulder I; Rensink I; Aarden LA
    FEBS Lett; 2007 Nov; 581(28):5382-8. PubMed ID: 17976375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental metastasis.
    Ostrowski LE; Ahsan A; Suthar BP; Pagast P; Bain DL; Wong C; Patel A; Schultz RM
    Cancer Res; 1986 Aug; 46(8):4121-8. PubMed ID: 3089587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional sites of glia-derived nexin (GDN): importance of the site reacting with the protease.
    Nick H; Hofsteenge J; Shaw E; Rovelli G; Monard D
    Biochemistry; 1990 Mar; 29(9):2417-21. PubMed ID: 2337608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased neurite development and plasminogen activator expression by exposure of human neuroblastoma cells to plasminogen-deficient growth medium.
    Becherer PR; Wachsman JT
    J Cell Physiol; 1980 Jul; 104(1):47-52. PubMed ID: 7192289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that a variety of cultured cells secrete protease nexin and produce a distinct cytoplasmic serine protease-binding factor.
    Eaton DL; Baker JB
    J Cell Physiol; 1983 Nov; 117(2):175-82. PubMed ID: 6579053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.